<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00835055</url>
  </required_header>
  <id_info>
    <org_study_id>43/05</org_study_id>
    <nct_id>NCT00835055</nct_id>
  </id_info>
  <brief_title>Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Claraspital AG</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Claraspital AG</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether markers on tumor tissue may be an indicator
      for good response to neoadjuvant chemoradiotherapy in patients with rectal cancer.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    never started several reasons
  </why_stopped>
  <start_date type="Actual">April 2005</start_date>
  <completion_date type="Actual">April 1, 2019</completion_date>
  <primary_completion_date type="Actual">April 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">0</enrollment>
  <condition>Rectal Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        group is selected from a single institution ( community hospital)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  locally advanced rectal cancer uT3 or uT4

          -  no distant metastasis

          -  neoadjuvant radiochemotherapy required

        Exclusion Criteria:

          -  rejection of radiochemotherapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>St. Claraspital, Chirurgische Klinik</name>
      <address>
        <city>Basel</city>
        <zip>4016</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>February 2, 2009</study_first_submitted>
  <study_first_submitted_qc>February 2, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 3, 2009</study_first_posted>
  <last_update_submitted>April 3, 2019</last_update_submitted>
  <last_update_submitted_qc>April 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Claraspital AG</investigator_affiliation>
    <investigator_full_name>Dr. Beatrice Kern</investigator_full_name>
    <investigator_title>Dr.med</investigator_title>
  </responsible_party>
  <keyword>rectal cancer with neoadjuvant treatment</keyword>
  <keyword>standardized clinical tests</keyword>
  <keyword>tumor markers on tumor tissue</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

